We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Regeneration Implant Enables Stem Cells to Grow Cartilage

By HospiMedica International staff writers
Posted on 15 Jan 2014
A novel off-the-shelf cartilage regeneration solution helps the body to regenerate true hyaline cartilage and bone.

The CartiHeal Agili-C implant is intended the treatment of focal articular cartilage and osteochondral defects. More...
The implant scaffold, made of coral, reproducibly regenerates hyaline cartilage and its underlying subchondral bone in a single-step procedure. Once the size of the defect is determined, a hole is prepared in the affected area and the implant is inserted in a press fit manner. Blood immediately infiltrates the interconnected pores of the implant, beginning a biological cascade culminating in bone and hyaline cartilage regeneration through migration, adhesion, proliferation, and differentiation of mesenchymal stem cells (MSCs) to simultaneously regenerate both bone and cartilage.

Within a few months, the top layer becomes true hyaline cartilage while the bottom layer turns to bone, with each tissue genetically identical to the body’s own tissues. The regenerated cells gradually biodegrade the implanted scaffold over time. The rigid, biphasic, implant is composed of biocompatible and biodegradable materials. The bone phase of the implant is composed of calcium carbonate in aragonite crystalline form, while the cartilage phase is a composite of modified aragonite and hyaluronic acid (HA). The Agili-C implant is a product of CartiHeal (Kfar Saba, Israel).

“Our clinical results to date confirm rapid cartilage and bone formation, as clearly visible on MRIs and X-rays. The newly formed cartilage is hyaline cartilage, the body’s native cartilage, distinguished by its specific type of collagen,” said Nir Altschuler, founder and CEO of CartiHeal. “Other experimental treatments generate only “hyaline-like” cartilage, which is actually a nonlasting fibrous tissue rather than the real deal.”

Hyaline cartilage is glossy blue-white in appearance and very resilient, and is the most widespread type of cartilage and makes up the embryonic skeleton. It persists in human adults at the ends of bones in free-moving joints such as the articular cartilage, at the ends of the ribs, and in the nose, larynx, trachea, and bronchi.

Related Links:
CartiHeal



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.